NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,088 filers reported holding NOVARTIS A G in Q3 2019. The put-call ratio across all filers is 0.92 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $509,300 | -96.1% | 5,000 | -96.4% | 0.00% | -97.6% |
| Q1 2023 | $12,916,800 | +162.3% | 140,400 | +116.7% | 0.04% | +105.0% |
| Q3 2022 | $4,925,000 | -46.8% | 64,800 | -35.7% | 0.02% | -4.8% |
| Q2 2019 | $9,252,000 | +53.8% | 100,800 | +60.5% | 0.02% | -16.0% |
| Q1 2019 | $6,014,000 | -14.1% | 62,800 | -29.1% | 0.02% | +25.0% |
| Q3 2016 | $7,001,000 | -6.3% | 88,597 | -2.9% | 0.02% | -16.7% |
| Q2 2016 | $7,468,000 | -95.1% | 91,240 | -94.5% | 0.02% | -94.1% |
| Q4 2014 | $152,832,000 | -19.8% | 1,650,000 | -18.5% | 0.41% | -20.9% |
| Q3 2014 | $190,644,000 | +28.1% | 2,025,129 | +22.7% | 0.52% | +1131.0% |
| Q2 2014 | $148,881,000 | -14.4% | 1,650,200 | -19.8% | 0.04% | -20.8% |
| Q1 2014 | $173,899,000 | +9028.6% | 2,057,731 | +8186.9% | 0.05% | +381.8% |
| Q3 2013 | $1,905,000 | -36.7% | 24,831 | -41.5% | 0.01% | -65.6% |
| Q1 2013 | $3,009,000 | +445.1% | 42,412 | +384.3% | 0.03% | +433.3% |
| Q4 2012 | $552,000 | – | 8,757 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PRENTISS SMITH & CO INC | 127,510 | $11,721,000 | 6.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 127,716 | $11,740,000 | 6.04% |
| EXENCIAL WEALTH ADVISORS, LLC | 116,917 | $10,747,000 | 5.25% |
| MCDANIEL TERRY & CO | 181,095 | $16,646,000 | 4.64% |
| Fayerweather Charles | 18,180 | $1,671,000 | 4.54% |
| Osher Van de Voorde Investment Management | 78,138 | $7,182,000 | 4.38% |
| BROWN BROTHERS HARRIMAN & CO | 9,291,495 | $854,074,000 | 4.35% |
| Boulegeris Investments, Inc. | 61,322 | $5,637,000 | 4.31% |
| DODGE & COX | 45,723,035 | $4,202,861,000 | 4.23% |
| WHV Investments, Inc. | 1,603,476 | $152,945,000 | 4.23% |